The New York Times today has a story on extending the life spans of doggies, a link will take you to TRIAD (Test of Rapamycin in Aging Dogs).
This is probably bad news for PAA. It’s proof positive that MARKETING works.
As I’ve stated before, in the money making game, science rarely wins. It’s about hype. PAA is a listed public company. Time for it to get fair dinkum.
FDA Application for Orphan Drug Designation , PAA, MPL, page-334
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.015(8.33%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 16.0¢ | $320.8K | 1.881M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 13586 | 3 |
View Market Depth
| Last trade - 15.59pm 07/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |